wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43
Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43
Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.
P2860
Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37308807-0404FE19-C9C7-495B-850F-CD3D735E6A43
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56162599450ba0c70215476a13f29d22e939fe13
P2860
Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.